Abstract
Although the number of pregnancies in women with cardiac disease is increasing worldwide, there are few data concerning their clinical characteristics and peripartum outcomes. Using the Diagnosis Procedure Combination database between 2008 and 2014 in Japan, we retrospectively identified pregnant women who underwent high-risk delivery due to obstetric or non-obstetric comorbidities. We classified eligible women into those with pre-existing cardiac disease (cardiac disease group) and those with non-cardiac comorbidities (non-cardiac disease group) and compared their characteristics and peripartum outcomes. Of 94,364 women undergoing high-risk delivery at 556 hospitals, 857 (0.91%) had pre-existing cardiac disease (302, congenital heart disease; 190, arrhythmia; 176, valvular heart disease; 120, ischemic heart disease; 65, cardiomyopathy; 4, pericardial disease). Women in the cardiac disease group were more likely to be treated at university hospitals (51.1 versus 28.6%; p < 0.001) and in intensive care units (33.5 versus 18.8%; p < 0.001) than those in the non-cardiac disease group. The proportion of cesarean deliveries was 69.4% (emergency, 28.4%; elective, 41.1%) in the cardiac disease group and 73.4% (emergency, 38.4%; elective, 35.0%) in the non-cardiac disease group. Epidural analgesia during vaginal delivery was used significantly more frequently in the cardiac disease than non-cardiac disease group (15.6 versus 2.3%; p < 0.001). Heart failure occurred more frequently in the cardiac disease than the non-cardiac disease group (10.2 versus 0.3%; p < 0.001). In cardiac subgroup comparisons, heart failure occurred more frequently in women with congenital heart disease (12.3%), valvular heart disease (12.5%), or cardiomyopathy (12.3%) than in women with arrhythmia (6.3%) or ischemic heart disease (5.8%). Multivariable logistic regression analysis showed a significant positive association between pre-existing cardiac disease and risk of heart failure (adjusted odds ratio, 24.7; 95% confidence interval, 17.6–34.6; p < 0.001). No woman in the cardiac disease group died, whereas 18 women (0.02%) in the non-cardiac disease group did (p = 1.000). These findings suggest that pregnant women with pre-existing cardiac disease are at a higher risk of heart failure during the peripartum period than those with non-cardiac comorbidities.
Similar content being viewed by others
References
Elkayam U, Goland S, Pieper PG, Silverside CK (2016) High-risk cardiac disease in pregnancy: part I. J Am Coll Cardiol 68:396–410
JCS Joint Working Group (2012) Guidelines for indication and management of pregnancy and delivery in women with heart disease (JCS 2010): digest version. Circ J 76:240–260
Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, Mital S, Rose C, Silversides C, Stout K, American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research (2017) Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation 135:e50–e87
Shiina Y, Toyoda T, Kawasoe Y, Tateno S, Shirai T, Wakisaka Y, Matsuo K, Mizuno Y, Terai M, Hamada H, Niwa K (2011) Prevalence of adult patients with congenital heart disease in Japan. Int J Cardiol 146:13–16
European Society of Gynecology, Association for European Paediatric Cardiology, German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L, ESC Committee for Practice Guidelines (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32:3147–3197
Williams RG, Pearson GD, Barst RJ, Child JS, del Nido P, Gersony WM, Kuehl KS, Landzberg MJ, Myerson M, Neish SR, Sahn DJ, Verstappen A, Warnes CA, Webb CL, National Heart Lung, and Blood Institute Working Group on research in adult congenital heart disease (2006) Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. J Am Coll Cardiol 47:701–707
Karamlou T, Diggs BS, McCrindle BW, Welke KF (2011) A growing problem: maternal death and peripartum complications are higher in women with grown-up congenital heart disease. Ann Thorac Surg 92:2193–2198
Roos-Hesselink JW, Ruys TP, Stein JI, Thilen U, Webb GD, Niwa K, Kaemmerer H, Baumgartner H, Budts W, Maggioni AP, Tavazzi L, Taha N, Johnson MR, Hall R, ROPAC Investigators (2013) Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J 34:657–665
Thompson JL, Kuklina EV, Bateman BT, Callaghan WM, James AH, Grotegut CA (2015) Medical and obstetric outcomes among pregnant women with congenital heart disease. Obstet Gynecol 126:346–354
Hunter S, Robson SC (1992) Adaptation of the maternal heart in pregnancy. Br Heart J 68:540–543
Elkayam U, Goland S, Pieper PG, Silverside CK (2016) High-risk cardiac disease in pregnancy: part II. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2016.05.050
Ruys TP, Cornette J, Roos-Hesselink JW (2013) Pregnancy and delivery in cardiac disease. J Cardiol 61:107–112
Knight M, Nair M, Tuffnell D, Kenyon S, Shakespeare J, Brocklehurst P, Kurinczuk JJ (eds); on behalf of MBRRACE-UK (2016) Saving lives, improving mothers’ care—surveillance of maternal deaths in the UK 2012–14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–14. National Perinatal Epidemiology Unit, University of Oxford, Oxford
Tanaka H, Katsuragi S, Osato K, Hasegawa J, Nakata M, Murakoshi T, Yoshimatsu J, Sekizawa A, Kanayama N, Ishiwata I, Ikeda T (2017) The increase in the rate of maternal deaths related to cardiovascular disease in Japan from 1991–1992 to 2010–2012. J Cardiol 69:74–78
Isogai T, Matsui H, Tanaka H, Fushimi K, Yasunaga H (2017) In-hospital management and outcomes in patients with peripartum cardiomyopathy: a descriptive study using a national inpatient database in Japan. Heart Vessels 32:944–951
Isogai T, Matsui H, Tanaka H, Fushimi K, Yasunaga H (2017) Seasonal variation in patient characteristics and in-hospital outcomes of Takotsubo syndrome: a nationwide retrospective cohort study in Japan. Heart Vessels 32:1271–1276
Ministry of Health, Labour and Welfare, Japan. http://www.mhlw.go.jp/shingi/2009/04/dl/s0422-4d.pdf (in Japanese). Accessed 15 Feb 2017
Hubbard AE, Ahern J, Fleischer NL, Van der Laan M, Lippman SA, Jewell N, Bruckner T, Satariano WA (2010) To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology 21:467–474
Maeda E, Ishihara O, Tomio J, Sato A, Terada Y, Kobayashi Y, Murata K (2017) Cesarean section rates and local resources for perinatal care in Japan: a nationwide ecological study using the national database of health insurance claims. J Obstet Gynaecol Res. https://doi.org/10.1111/jog.13518
EURO-PERISTAT Project, with SCPE, EUROCAT, EURONEOSTAT. European Perinatal Health Report 2010. http://www.europeristat.com/reports.html. Accessed 25 Aug 2017
Ruys TP, Roos-Hesselink JW, Pijuan-Domenech A, Vasario E, Gaisin IR, Iung B, Freeman LJ, Gordon EP, Pieper PG, Hall R, Boersma E, Johnson MR, Investigators ROPAC (2015) Is a planned caesarean section in women with cardiac disease beneficial? Heart 101:530–536
Tanaka H, Kamiya C, Katsuragi S, Tanaka K, Miyoshi T, Tsuritani M, Yoshida M, Iwanaga N, Neki R, Yoshimatsu J, Ikeda T (2014) Cardiovascular events in pregnancy with hypertrophic cardiomyopathy. Circ J 78:2501–2506
Katsuragi S, Kamiya C, Yamanaka K, Neki R, Miyoshi T, Iwanaga N, Horiuchi C, Tanaka H, Yoshimatsu J, Niwa K, Ikeda T (2013) Risk factors for maternal and fetal outcome in pregnancy complicated by Ebstein anomaly. Am J Obstet Gynecol 209(452):e1–e6
Tanaka H, Katsuragi S, Tanaka K, Sawada M, Iwanaga N, Yoshimatsu J, Yoshimatsu J, Ikeda T (2016) Maternal and neonatal outcomes in labor and at delivery when long QT syndrome is present. J Matern Fetal Neonatal Med 29:1117–1119
Ohuchi H, Tanabe Y, Kamiya C, Noritake K, Yasuda K, Miyazaki A, Ikeda T, Yamada O (2013) Cardiopulmonary variables during exercise predict pregnancy outcome in women with congenital heart disease. Circ J 77:470–476
Hidano G, Uezono S, Terui K (2011) A retrospective survey of adverse maternal and neonatal outcomes for parturients with congenital heart disease. Int J Obstet Anesth 20:229–235
Niwa K, Tateno S, Akagi T, Himeno W, Kawasoe Y, Tatebe S, Matsuo K, Gatzoulis MA, Nakazawa M (2007) Arrhythmia and reduced heart rate variability during pregnancy in women with congenital heart disease and previous reparative surgery. Int J Cardiol 122:143–148
Tateno S, Niwa K, Nakazawa M, Akagi T, Shinohara T, Yasuda T, Study Group for Arrhythmia Late after Surgery for Congenital Heart Disease (ALTAS-CHD) (2003) Arrhythmia and conduction disturbances in patients with congenital heart disease during pregnancy: multicenter study. Circ J 67:992–997
Tsuda E, Kawamata K, Neki R, Echigo S, Chiba Y (2006) Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan. Cardiol Young 16:173–178
Goldszmidt E, Macarthur A, Silversides C, Colman J, Sermer M, Siu S (2010) Anesthetic management of a consecutive cohort of women with heart disease for labor and delivery. Int J Obstet Anesth 19:266–272
Ituk US, Habib AS, Polin CM, Allen TK (2015) Anesthetic management and outcomes of parturients with dilated cardiomyopathy in an academic centre. Can J Anaesth 62:278–288
Terui K (2009) Comparison of the obstetric anesthesia practice between Japan and U.S.A. Masui 58:1473–1475 (in Japanese)
Eltzschig HK, Lieberman ES, Camann WR (2003) Regional anesthesia and analgesia for labor and delivery. N Engl J Med 348:319–332
Palot M, Leymarie F, Jolly DH, Visseaux H, Botmans-Daigremont C, Mariscal-Causse A (2006) Request of epidural analgesia by women and obstetrical teams in four French areas. Part II: management of epidural analgesia. Ann Fr Anesth Reanim 25:569–576 (in French)
Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H (2017) Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 27:476–482
Kuklina EV, Callaghan WM (2010) Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004–2006. Obstet Gynecol 115:93–100
Lima FV, Parikh PB, Zhu J, Yang J, Stergiopoulos K (2015) Association of cardiomyopathy with adverse cardiac events in pregnant women at the time of delivery. JACC Heart Fail 3:257–266
Balci A, Sollie-Szarynska KM, van der Bijl AG, Ruys TP, Mulder BJ, Roos-Hesselink JW, van Dijk AP, Wajon EM, Vliegen HW, Drenthen W, Hillege HL, Aarnoudse JG, van Veldhuisen DJ, Pieper PG, ZAHARA-II Investigators (2014) Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart 100:1373–1381
Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, Bergin ML, Kiess MC, Marcotte F, Taylor DA, Gordon EP, Spears JC, Tam JW, Amankwah KS, Smallhorn JF, Farine D, Sorensen S, Disease Cardiac, in Pregnancy (CARPREG) Investigators (2001) Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104:515–521
Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, Vliegen HW, van Dijk AP, Voors AA, Yap SC, van Veldhuisen DJ, Pieper PG, ZAHARA Investigators (2010) Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 31:2124–2132
Funding
This work was supported by Grants from the Ministry of Health, Labour and Welfare, Japan (Grant Numbers: H29-Policy-Designated-009 and H29-ICT-General-004); the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant Number: 17H04141); and the Japan Agency for Medical Research and Development (AMED). The funders had no role in the execution of this study or the interpretation of the results.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was approved by The Institutional Review Board at The University of Tokyo.
Informed consent
The requirement for informed consent was waived because all data in the DPC database are anonymized.
Appendix
Appendix
The following International Classification of Diseases, 10th Revision code (ICD-10) codes were used to identify diseases. Use of both a Japanese-text diagnosis and an ICD-10 code to identify a disease is designated by placing “with Japanese-text” after the ICD-10 code.
Cardiac disease Congenital heart disease (Q20.x–Q24.x); ventricular septal defect (Q21.0); atrial septal defect (Q21.1 with Japanese-text); atrioventricular septal defect (Q21.2); tetralogy of Fallot (Q21.3); double outlet right ventricle (Q20.1); complete transposition of great arteries (Q20.3 with Japanese-text); corrected transposition of great arteries (Q20.5 with Japanese-text); Ebstein anomaly (Q22.5); unspecified congenital malformation of heart (Q24.9); second degree atrioventricular block (I44.1); third degree atrioventricular block (I44.2); Wolff–Parkinson–White syndrome (I45.6 with Japanese-text); supraventricular tachycardia (I47.1); atrial fibrillation/flutter (I48.0); sick sinus syndrome (I49.5); post-implantation of cardiac implantable electronic device (Z95.0, Z95.8 with Japanese-text); long QT syndrome (I49.0 with Japanese-text); Brugada syndrome (I49.0 with Japanese-text); valvular heart disease (I34.x–I37.x); non-rheumatic valve disease (I34.x–I36.x); mitral valve prolapse or regurgitation (I34.0, I34.1); aortic stenosis (I35.0); aortic regurgitation (I35.1); aortic stenosis with regurgitation (I35.2); rheumatic valve disease (I05.x–I09.x); mitral stenosis (I05.0); mitral stenosis with regurgitation (I05.2); tricuspid regurgitation (I07.1); tricuspid stenosis with regurgitation (I07.2); pulmonary valve disease (I37.x); pulmonary heart disease (I27.x, I28.x); Marfan syndrome (Q87.4); angina pectoris (I20.0); chronic ischemic heart disease (I25.x); coronary artery disease of Kawasaki disease (coronary artery aneurysm or ischemic heart disease, M303 with Japanese-text); cardiomyopathy (I42.x, I43.x); dilated cardiomyopathy (I42.0 with Japanese-text); obstructive hypertrophic cardiomyopathy (I42.1); non-obstructive hypertrophic cardiomyopathy (I42.2); endocardial fibroelastosis (I42.4); arrhythmogenic right ventricular cardiomyopathy (I42.8 with Japanese-text); pericardial disease (I31.x, I32.x); post-cardiac surgery (Z95.1–Z95.5 with Japanese-text).
Comorbidity Gestational hypertension (O13.x); pre-eclampsia or eclampsia (O11.x, O14.x, O15.x); chronic hypertension (I10.x, I15.x, O10.x); diabetes mellitus (E10–14.x, O24.x); anemia (D46.x, D50.x, D51.x, D52.x, D53.x, D55.x, D56.x, D58.x, D59.x, D60.x, D62, D63.x, D64.x, O99.0); history of uterine surgery including cesarean section (O34.2); multiple gestation (O30.x); fetal malpresentation (O32.x); cephalopelvic disproportion (O33.x); premature rupture of membranes (O42.x); threatened premature labor (O47.0 with Japanese text); intrauterine fetal growth restriction (O36.5); fetal distress (O68.x); placental disorders (O43.x); obstructed labor (O64.x–O66.x); placenta previa (O44.x); placental abruption (O45.x).
Outcome Heart failure (I11.0, I13.0, I13.2, I50.x); ventricular fibrillation (I49.0 with Japanese text); acute myocardial infarction (I21.x with Japanese text); pulmonary embolism (I26.x); cerebral infarction (I63.x); intracerebral hemorrhage (I61.x).
Rights and permissions
About this article
Cite this article
Isogai, T., Matsui, H., Tanaka, H. et al. Clinical features and peripartum outcomes in pregnant women with cardiac disease: a nationwide retrospective cohort study in Japan. Heart Vessels 33, 918–930 (2018). https://doi.org/10.1007/s00380-018-1137-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-018-1137-1